Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Distribution Agreement: Food DetectiveT in India

26 Nov 2010 07:00

RNS Number : 8411W
Omega Diagnostics Group PLC
26 November 2010
 



 

Omega Diagnostics Group PLC

("Omega")

Distribution Agreement for Food Detective™ in India

 

Omega, a leading producer of diagnostic testing kits for Food Intolerance announces that its subsidiary, Cambridge Nutritional Sciences Limited, has signed an exclusive distribution agreement with existing marketing partner Thermo Fisher Scientific India Pvt. Ltd. (TFSI) covering the sale and distribution of its Food Detective™ product into the Indian market. The product has recently been approved by the Indian authorities therefore marketing and sale of the product will commence immediately.

 

Mr Andrew Shepherd, CEO of Omega, said: "We're very pleased to announce this deal with TFSI for distribution of Food Detective™ in India which expands our successful business relationship in this strategic market for the company. The product is now being used in over 50 countries and sales for the six months ending 30 September 2010 were £369,000. The Indian Agreement is expected to lead to additional sales of approximately £300,000 over the next three years. This product is well accepted as being a reliable test for those people suffering from the effects of food intolerance. This cost effective test has great potential in the Indian market which will provide a rapid means for more people to realise if their chronic symptoms are food related."

 

Commenting on the distribution agreement, Mr Girish Mehta, Director of TFSI said: "Food Detective™ is a unique product which will address the long unmet demand of identifying food intolerance amongst Indians. This product has been customised for the Indian food diet and has been priced affordably to reach a large population. Thermo Fisher Scientific India with its well-trained and experienced technical and sales teams is well positioned to market Food Detective™ in India and we hope that it will be a big success."

 

Omega Diagnostics Group PLC

Tel: 01259 763 030

Andrew Shepherd, Chief Executive

Kieron Harbinson, Group Finance Director

www.omegadiagnostics.com

Cenkos Securities plc

Tel: 020 7397 8900

Ian Soanes

Elizabeth Bowman

Walbrook PR Limited

Tel: 020 7933 8787

Paul McManus

Mob: 07980 541 893

 

paul.mcmanus@walbrookpr.com

Paul Cornelius

Tel: 020 7933 8794

 

Mob: 07866 384 707

 

paul.cornelius@walbrookir.com

 

 

 

Information on Omega Diagnostics Group PLC:

Omega sells 86% of production (by turnover) through a network of distributors in over 100 countries. The largest distributor by sales value in the year ending 31 March 2010 was TFSI accounting for approximately 8% of Omega's sales in that financial year.

 

Information on Thermo Fisher Scientific India Pvt. Ltd. /Thermo Fisher Scientific (TFS):

Thermo Fisher Scientific India (TFSI) is the wholly owned subsidiary of Thermo Fisher Scientific USA (TFS) and is a USD 150 million sales organization. TFS is the world wide leader in serving science and offers one-stop-shop solutions to scientific laboratories associated with research, academia, industry, diagnostic testing, quality control, quality assurance etc. TFSI employs over 650 highly qualified and trained personnel to serve the needs of the Indian market and currently offers a wide range of products ranging from state-of-the-art scientific instruments to the smallest of laboratory consumables.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRPGGMUGUPUGMA
Date   Source Headline
2nd Mar 20217:00 amRNSContract with Screen4
24th Feb 20217:00 amRNSUK-RTC statement on AbC-19TM rapid antibody test
19th Feb 20211:45 pmRNSDirector/PDMR Shareholding
18th Feb 202110:00 amRNSDirector/PDMR Shareholding
16th Feb 20217:00 amRNSAbC-19TM rapid antibody test performance data
15th Feb 20217:00 amRNSDirector/PDMR Shareholding
11th Feb 20219:00 amRNSPrice Monitoring Extension
11th Feb 20217:01 amRNSUK Government contract and trading update
11th Feb 20217:00 amRNSDirectorate Change
8th Feb 20219:05 amRNSSecond Price Monitoring Extn
8th Feb 20219:00 amRNSPrice Monitoring Extension
8th Feb 20217:00 amRNSStatement re Media Comment
2nd Feb 20218:45 amRNSExercise of Options and Total Voting Rights
28th Jan 20211:15 pmRNSExercise of Options and Total Voting Rights
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:35 pmRNSPrice Monitoring Extension
26th Jan 20217:02 amRNSLab-based COVID-19 antibody test service launch
26th Jan 20217:01 amRNSUpdate re AbC-19 Rapid Test
25th Jan 202111:06 amRNSSecond Price Monitoring Extn
25th Jan 202111:00 amRNSPrice Monitoring Extension
22nd Jan 202110:15 amRNSExercise of Options and Total Voting Rights
22nd Jan 20219:05 amRNSSecond Price Monitoring Extn
22nd Jan 20219:00 amRNSPrice Monitoring Extension
11th Jan 202111:00 amRNSExercise of Options and Total Voting Rights
29th Dec 20207:01 amRNSUpdate re AbC-19 Rapid Test
29th Dec 20207:00 amRNSAbC-19TM Rapid Test Update
24th Dec 202012:41 pmRNSSecond Price Monitoring Extn
24th Dec 202012:35 pmRNSPrice Monitoring Extension
24th Dec 202012:00 pmRNSMologic CE Mark Rapid Antigen Test
24th Dec 202011:05 amRNSSecond Price Monitoring Extn
24th Dec 202011:00 amRNSPrice Monitoring Extension
11th Dec 20202:05 pmRNSSecond Price Monitoring Extn
11th Dec 20202:00 pmRNSPrice Monitoring Extension
11th Dec 20209:45 amRNSExercise of Options and Total Voting Rights
7th Dec 20208:00 amRNSExercise of Options and Total Voting Rights
2nd Dec 20209:00 amRNSDirector/PDMR Shareholding
30th Nov 20202:30 pmRNSExercise of Options and Total Voting Rights
30th Nov 20207:00 amRNSInterim Results
25th Nov 20202:06 pmRNSSecond Price Monitoring Extn
25th Nov 20202:01 pmRNSPrice Monitoring Extension
23rd Nov 20209:45 amRNSExercise of Options and Total Voting Rights
17th Nov 20207:45 amRNSUK-RTC Update
16th Nov 20207:16 amRNSHolding(s) in Company
16th Nov 20207:15 amRNSHolding(s) in Company
13th Nov 20202:05 pmRNSSecond Price Monitoring Extn
13th Nov 20202:00 pmRNSPrice Monitoring Extension
13th Nov 20209:30 amRNSExercise of Options and Total Voting Rights
12th Nov 20203:42 pmRNSUK-RTC Statement
12th Nov 202011:05 amRNSSecond Price Monitoring Extn
12th Nov 202011:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.